Arrowhead PharmaceuticalsARWR 
$20.783.85%24h
3.85%24h
Global rank4428
Market cap$2.22B
Change 7d-5.55%
YTD Performance-31.87%
SP500 benchmarkUnderperform
P/E-10.82
P/S9.21
Revenue$240.74M
Earnings-$209.28M
Dividend yield-
Main Sector
Healthcare
EPS for Arrowhead Pharmaceuticals (ARWR)
Arrowhead Pharmaceuticals has an EPS of $-1.92. In 2022, the company made an earnings per share (EPS) of $-1.67. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for ARWR
-
Value:-
EPS history for Arrowhead Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$1.92 | 14.97% |
| 2022 | -$1.67 | 22.79% |
| 2021 | -$1.36 | 61.90% |
| 2020 | -$0.84 | - |
View the highest EPS stocks
